HIGHLIGHTS
- who: Uddhav Timilsina from the Jacobs School University at Buffalo, Buffalo, NY, USA have published the research: SARS-CoV-2 ORF7a potently inhibits the antiviral effect of the host factor SERINC5, in the Journal: NATURE COMMUNICATIONS NATURE COMMUNICATIONS
- what: The authors demonstrate that SARS-CoV-2 ORF7a, a SARS-CoV-2 accessory protein, counteracts the antiviral effect of SERINC5. For the work the authors focused on ORF7a, a type I transmembrane protein of 121 amino_acids that is very similar (85% sequence identity) with SARS-CoV ORF7a40. In this report, the authors focused on identifying a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.